AILISH GARRETT: Open Payments
NPI 1679827570 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 59 payments from 26 companies in 2025. Trend: 2023 $535 · 2024 $535 · 2025 $1,718
Food & beverage: $1,619Education: $99
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $235 |
| Celgene Corporation | 5 | $232 |
| Janssen Biotech, Inc. | 4 | $220 |
| Regeneron Healthcare Solutions, Inc. | 8 | $140 |
| Incyte Corporation | 3 | $75 |
| Merck Sharp & Dohme LLC | 2 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| PharmaEssentia USA Corporation | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
Products named: REBLOZYL, Enhertu, LIBTAYO, CARVYKTI, RYBREVANT, KEYTRUDA, Nubeqa, BESREMI.
Industry payments across TN — which companies pay providers there.
